Drugs that contain Ceftaroline Fosamil

1. Drug name - TEFLARO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6417175 ALLERGAN Phosphonocephem derivatives, process for the preparation of the same, and use thereof
Apr, 2022

(5 months ago)

CN1282335A ALLERGAN Phosphoryl Derivatives, Their Preparation And Use
Dec, 2018

(3 years ago)

CN1194980C ALLERGAN Phosphoryl Derivatives, Their Preparation And Use
Dec, 2018

(3 years ago)

CN1679595B ALLERGAN Phosphonoalkane Derivatives, Their Preparation And Use
Dec, 2018

(3 years ago)

CN1679595A ALLERGAN Phosphoryl Derivatives, Their Preparation And Use
Dec, 2018

(3 years ago)

EP1043327A1 ALLERGAN Phosphonocephem Derivatives, Process For The Preparation Of The Same, And Use Thereof
Dec, 2023

(1 year, 2 months from now)

EP1043327B1 ALLERGAN Phosphonocephem Derivatives, Process For The Preparation Of The Same, And Use Thereof
Dec, 2023

(1 year, 2 months from now)

EP1043327A4 ALLERGAN Phosphonocephem Derivatives, Process For The Preparation Of The Same, And Use Thereof
Dec, 2023

(1 year, 2 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9629861 ALLERGAN Compositions and methods for treating bacterial infections using ceftaroline Sep, 2030

(7 years from now)

US8247400 ALLERGAN Cephem compounds useful for the treatment of bacterial infections Feb, 2031

(8 years from now)

Treatment: Method of treating bacterial infections

Dosage: POWDER;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
400MG/VIAL POWDER;INTRAVENOUS Prescription
600MG/VIAL POWDER;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.